Table 13.6c

Immunosuppression Use: Maintenance Between Discharge

and One Year Posttransplant, 1992 to 2001

Recipients with Heart-Lung Transplants

		Year of Transplant
		1992	1993	1994	1995	1996	1997	1998	1999	2000	2001
Transplants		48	60	71	69	39	61	47	51	48	27
Tx With Follow-up Immunosuppression Info		31	44	45	53	22	32	27	27	29	20
Corticosteroids	Category Usage	100.0%	97.7%	100.0%	100.0%	100.0%	100.0%	96.3%	100.0%	100.0%	95.0%
	Steroids	100.0%	97.7%	100.0%	100.0%	100.0%	100.0%	96.3%	100.0%	100.0%	95.0%
Cyclosporine	Category Usage	80.6%	86.4%	93.3%	58.5%	86.4%	59.4%	66.7%	55.6%	58.6%	50.0%
	Cyclosporin	80.6%	86.4%	86.7%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
	Sandimmmune	0.0%	2.3%	6.7%	34.0%	36.4%	6.3%	0.0%	0.0%	6.9%	0.0%
	Neoral	3.2%	0.0%	2.2%	35.8%	50.0%	53.1%	66.7%	55.6%	44.8%	45.0%
	Gengraf	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	6.9%	5.0%
Tacrolimus	Category Usage	19.4%	13.6%	6.7%	30.2%	13.6%	43.8%	37.0%	51.9%	58.6%	75.0%
	FK506	19.4%	13.6%	6.7%	30.2%	13.6%	43.8%	37.0%	51.9%	58.6%	75.0%
Antimetabolites	Category Usage	96.8%	93.2%	95.6%	88.7%	81.8%	87.5%	92.6%	92.6%	93.1%	95.0%
	Azathioprine	96.8%	93.2%	93.3%	73.6%	68.2%	62.5%	44.4%	48.1%	44.8%	50.0%
	Mycophenolate mofetil	0.0%	0.0%	2.2%	22.6%	13.6%	34.4%	51.9%	48.1%	62.1%	60.0%
Other	Category Usage	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	7.4%	3.7%	10.3%	0.0%
	Rapamycin	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	7.4%	3.7%	10.3%	0.0%
	Cytoxan	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Source: OPTN/SRTR Data as of August 1, 2003.

Individual drug percentages will not necessarily add up to the drug category percentages, as patients may

be prescribed more than one drug within the same category.